115 related articles for article (PubMed ID: 8707423)
1. Clonality and stability of the p53 gene in human astrocytic tumor cells: quantitative analysis of p53 gene mutations by yeast functional assay.
Tada M; Iggo RD; Ishii N; Shinohe Y; Sakuma S; Estreicher A; Sawamura Y; Abe H
Int J Cancer; 1996 Jul; 67(3):447-50. PubMed ID: 8707423
[TBL] [Abstract][Full Text] [Related]
2. Reappraisal of p53 mutations in human malignant astrocytic neoplasms by p53 functional assay: comparison with conventional structural analyses.
Tada M; Iggo RD; Waridel F; Nozaki M; Matsumoto R; Sawamura Y; Shinohe Y; Ikeda J; Abe H
Mol Carcinog; 1997 Mar; 18(3):171-6. PubMed ID: 9115587
[TBL] [Abstract][Full Text] [Related]
3. Clonal expansion of p53 mutant cells is associated with brain tumour progression.
Sidransky D; Mikkelsen T; Schwechheimer K; Rosenblum ML; Cavanee W; Vogelstein B
Nature; 1992 Feb; 355(6363):846-7. PubMed ID: 1311419
[TBL] [Abstract][Full Text] [Related]
4. [Detectability and diagnostic criteria of p53 gene mutations in human oral squamous cell carcinoma using yeast functional assay].
Kashiwazaki H
Hokkaido Igaku Zasshi; 1997 Mar; 72(2):211-24. PubMed ID: 9145313
[TBL] [Abstract][Full Text] [Related]
5. Timing of p53 mutations during astrocytoma tumorigenesis.
del Arco A; García J; Arribas C; Barrio R; Blázquez MG; Izquierdo JM; Izquierdo M
Hum Mol Genet; 1993 Oct; 2(10):1687-90. PubMed ID: 8268922
[TBL] [Abstract][Full Text] [Related]
6. p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression.
Fults D; Brockmeyer D; Tullous MW; Pedone CA; Cawthon RM
Cancer Res; 1992 Feb; 52(3):674-9. PubMed ID: 1346255
[TBL] [Abstract][Full Text] [Related]
7. Molecular genetic analysis of p53 intratumoral heterogeneity in human astrocytic brain tumors.
Ren ZP; Olofsson T; Qu M; Hesselager G; Soussi T; Kalimo H; Smits A; Nistér M
J Neuropathol Exp Neurol; 2007 Oct; 66(10):944-54. PubMed ID: 17917588
[TBL] [Abstract][Full Text] [Related]
8. Validation of a yeast functional assay for p53 mutations using clonal sequencing.
Iggo R; Rudewicz J; Monceau E; Sevenet N; Bergh J; Sjoblom T; Bonnefoi H
J Pathol; 2013 Dec; 231(4):441-8. PubMed ID: 23897043
[TBL] [Abstract][Full Text] [Related]
9. [Analysis of transcript mutations due to transcriptional slippage in rat p53 tumor suppressor gene with the use of yeast functional assay].
Ba Y
Hokkaido Igaku Zasshi; 1999 May; 74(3):173-88. PubMed ID: 10422562
[TBL] [Abstract][Full Text] [Related]
10. Loss of heterozygosity of a locus on 17p13.3, independent of p53, is associated with higher grades of astrocytic tumours.
Chattopadhyay P; Rathore A; Mathur M; Sarkar C; Mahapatra AK; Sinha S
Oncogene; 1997 Aug; 15(7):871-4. PubMed ID: 9266974
[TBL] [Abstract][Full Text] [Related]
11. Incidence and timing of p53 mutations during astrocytoma progression in patients with multiple biopsies.
Watanabe K; Sato K; Biernat W; Tachibana O; von Ammon K; Ogata N; Yonekawa Y; Kleihues P; Ohgaki H
Clin Cancer Res; 1997 Apr; 3(4):523-30. PubMed ID: 9815715
[TBL] [Abstract][Full Text] [Related]
12. [Functional significance of p53 gene mutation in astrocytic neoplasms].
Tada M
No To Shinkei; 1998 Jun; 50(6):497-509. PubMed ID: 9656245
[No Abstract] [Full Text] [Related]
13. [Evaluation of yeast functional assay to detect p53 gene mutation in minute endoscopic samples of colonic mucosal neoplasia].
Nakamura Y
Hokkaido Igaku Zasshi; 1998 Sep; 73(5):505-17. PubMed ID: 9846280
[TBL] [Abstract][Full Text] [Related]
14. Altered structure and expression of the p53 gene in human neuroepithelial tumors.
Tabuchi K; Fukuyama K; Mineta T; Oh-Uchida M; Hori K
Neurol Med Chir (Tokyo); 1992 Sep; 32(10):725-32. PubMed ID: 1280773
[TBL] [Abstract][Full Text] [Related]
15. Homozygous p53 gene mutation in a radiation-induced glioblastoma 10 years after treatment for an intracranial germ cell tumor: case report.
Tada M; Sawamura Y; Abe H; Iggo R
Neurosurgery; 1997 Feb; 40(2):393-6. PubMed ID: 9007876
[TBL] [Abstract][Full Text] [Related]
16. Dominant-negative mutations of the tumor suppressor p53 relating to early onset of glioblastoma multiforme.
Marutani M; Tonoki H; Tada M; Takahashi M; Kashiwazaki H; Hida Y; Hamada J; Asaka M; Moriuchi T
Cancer Res; 1999 Oct; 59(19):4765-9. PubMed ID: 10519380
[TBL] [Abstract][Full Text] [Related]
17. Detection of p53 gene mutations in human brain tumors by single-strand conformation polymorphism analysis of polymerase chain reaction products.
Mashiyama S; Murakami Y; Yoshimoto T; Sekiya T; Hayashi K
Oncogene; 1991 Aug; 6(8):1313-8. PubMed ID: 1886708
[TBL] [Abstract][Full Text] [Related]
18. Detection of a novel point mutation in the p53 gene in grade II astrocytomas by PCR-SSCP analysis with additional Klenow treatment.
Chawengchao B; Petmitr S; Ponglikitmongkol M; Chanyavanich V; Sangruji T; Theerapuncharoen V; Hayashi K; Thangnipon W
Anticancer Res; 2001; 21(4A):2739-43. PubMed ID: 11724349
[TBL] [Abstract][Full Text] [Related]
19. Selective detection of inactivating mutations of the tumor suppressor gene p53 in bladder tumors.
Pfister C; Flaman JM; Martin C; Grise P; Frebourg T
J Urol; 1999 Jun; 161(6):1973-5. PubMed ID: 10332483
[TBL] [Abstract][Full Text] [Related]
20. Molecular genetic alterations in radiation-induced astrocytomas.
Brat DJ; James CD; Jedlicka AE; Connolly DC; Chang E; Castellani RJ; Schmid M; Schiller M; Carson DA; Burger PC
Am J Pathol; 1999 May; 154(5):1431-8. PubMed ID: 10329596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
